Last reviewed · How we verify
Ethidronate — Competitive Intelligence Brief
phase 1
Type IV secretion-like conjugative transfer relaxase protein TraI
Other
Small molecule
Live · refreshed every 30 min
Target snapshot
Ethidronate (Ethidronate) — Centre National d'Etudes Spatiales.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ethidronate TARGET | Ethidronate | Centre National d'Etudes Spatiales | phase 1 | Type IV secretion-like conjugative transfer relaxase protein TraI | ||
| Etidronate | Etidronate | Organon and Co | phase 3 | Type IV secretion-like conjugative transfer relaxase protein TraI |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ethidronate CI watch — RSS
- Ethidronate CI watch — Atom
- Ethidronate CI watch — JSON
- Ethidronate alone — RSS
Cite this brief
Drug Landscape (2026). Ethidronate — Competitive Intelligence Brief. https://druglandscape.com/ci/ethidronate. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing